Detailed Mechanism Funding and Narrative

Years of mechanism: 2008 2009

Details for Mechanism ID: 8267
Country/Region: Rwanda
Year: 2009
Main Partner: World Health Organization
Main Partner Program: NA
Organizational Type: Multi-lateral Agency
Funding Agency: HHS/CDC
Total Funding: $70,000

Funding for Care: TB/HIV (HVTB): $70,000

ACTIVITY HAS BEEN MODIFIED IN THE FOLLOWING WAYS:

In FY 2009, with funding through CDC-WHO central mechanism, WHO in Rwanda will continue supporting

the national TB/HIV program in training, monitoring, supervision, and add on MDR and X-DR TB

surveillance. Specifically, WHO will recruit another national project officer (NPO) to oversee MDR and X-DR

related activities, work with facilities to find all TB patients who failed first line and second line therapies, and

ensure that MDR cases adhere to their treatment regimens. The NPO will work with the National Reference

Laboratory for identification and diagnosis of second-line drug resistance among MDR patients who fail

treatment or die during treatment.

WHO will continue to train hospital staff including administrative directors on TB infection control and

support them to draft and implement plans based on available funds from PEPFAR implementing partners

and Global Fund support at the site level. WHO will expand physician training on TB diagnostics including

chest radiography and atypical presentation of pulmonary disease in PLHI. As a result, 100 more MDs will

be trained. In addition, WHO with PEPFAR support will train 30 MDs and hospital directors from GFATM

zones.

WHO will continue to facilitate monthly supervision of TB/HIV activities in districts by leading the team of

supervisors located at PNILT, TRAC, FHI, AIDSRelief and CDC. This supervision will consist of reviewing

data and providing sites with feedback on achievements and needed changes. Under the leadership of

WHO, the team will organize periodic cross-learning visits with implementing partners and site staff to sites

where best practices are exhibited for TB/HIV collaboration activities. In addition, WHO will facilitate a

national discussion on the use of Isoniazid in preventing TB among PLHIV (including children) based on

current available data. In collaboration with CDC direct TB/HIV program activities, two meetings will be

organized for district hospital to present their infection control plans. The plans will be reviewed by experts

and lessons learned in implementing infection control at district hospital will be shared. In order to better

control nosocomial infections based on lessons learned from TB infection control, WHO will draft a general

infection control plan to be implemented at Kigali national teaching hospital. Experiences from that facility

will serve to draft national guidelines on infection control in Rwanda.

The technical assistance provided by CDC in collaboration with WHO/OGAC and Columbia UTAP will

enhance the quality of national TB/HIV program

New/Continuing Activity: Continuing Activity

Continuing Activity: 18827

Continued Associated Activity Information

Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds

System ID System ID

18827 18827.08 HHS/Centers for World Health 8267 8267.08 WHO Stop TB $280,000

Disease Control & Organization

Prevention

Emphasis Areas

Human Capacity Development

Estimated amount of funding that is planned for Human Capacity Development $50,000

Public Health Evaluation

Food and Nutrition: Policy, Tools, and Service Delivery

Food and Nutrition: Commodities

Economic Strengthening

Education

Water

Table 3.3.12:

Cross Cutting Budget Categories and Known Amounts Total: $50,000
Human Resources for Health $50,000